MedTrace Logo

Mitral Valve Prolapse (MVP) - France Study

NCT00799565 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1179

Last updated 2011-07-14

No results posted yet for this study

Summary

This prospective nation-wide (France) study aims to search for susceptibility genes in MVP using a genome wide analysis and comparing results obtained in 1000 patients with MVP and 1000 non-MVP subjects.

Conditions

  • Mitral Valve Prolapse

Interventions

GENETIC

catch of blood

4 tubes of blood are taken on subjects. Samples are sent in Pr Jeunemaître to extract DNA and stock it. This DNA bank aims to search for susceptibility genes in MVP using a genome wide analysis and comparing results obtained in 1000 patients with MVP and 1000 non-MVP subjects

Sponsors & Collaborators

  • Leducq Foundation

    collaborator OTHER

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • Centre National de Génotypage

    collaborator OTHER

  • French Cardiology Society

    lead OTHER

Principal Investigators

  • Albert Alain Hagège, MD, PhD · Hôpital Européen Georges-Pompidou

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00799565 on ClinicalTrials.gov